Infiuss Health's Probe platform is a decentralized clinical trial management system that gives sponsors a single dashboard to identify and select research sites across Africa, remotely recruit and screen participants, collect electronic consent, manage data, and provide virtual study support. It addresses the structural exclusion of African populations from global clinical research: despite Africans representing 17% of the global population, less than 2% of clinical research is conducted in sub-Saharan Africa, limiting the diversity and generalizability of trial data. Its differentiator is a dual system combining sponsor-facing software with an on-the-ground site administrator network across Africa, enabling both fully remote and hybrid study designs across indications including infectious disease, rare disease, hematology, maternal health, and neglected tropical diseases.